Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Ended earlyNCT00287742
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Janssen Pharmaceutical K.K. 33
Early research (Phase 1)Not Yet RecruitingNCT06980207
What this trial is testing

A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 40
Early research (Phase 1)UnknownNCT06388551
What this trial is testing

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 60
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07459660
What this trial is testing

An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

Who this might be right for
Psychosis Associated With Alzheimer's Disease
MapLight Therapeutics 210
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Testing effectiveness (Phase 2)Looking for participantsNCT06887192
What this trial is testing

Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Who this might be right for
Psychosis Associated With Alzheimer's Disease
MapLight Therapeutics 300